Multimodal Management of Hypertension: Synergy Between Conventional and Alternative Therapies

Multimodal management of hypertension reflects the complex pathophysiology of the disorder, which arises from sympathetic overactivity, renin–angiotensin–aldosterone system dysregulation, and endothelial dysfunction, further influenced by lifestyle, genetic, and comorbid factors. Conventional pharmacotherapy remains the cornerstone, with diuretics, ACE inhibitors/ARBs, β-blockers, and calcium channel blockers forming the core classes, while combination regimens, fixed-dose preparations, and mineralocorticoid receptor antagonists provide additional efficacy in resistant disease. Complementary strategies add further therapeutic value, particularly lifestyle interventions such as DASH-pattern nutrition with sodium restriction, structured physical activity, weight reduction, and moderation of alcohol and tobacco intake, which exert significant blood pressure–lowering and cardiometabolic benefits. Nutraceuticals and botanicals, including garlic, hibiscus, omega-3 fatty acids, and coenzyme Q10, demonstrate promising effects, while mind–body practices such as yoga, meditation, and paced breathing contribute to autonomic balance and vascular regulation. Acupuncture offers modest reductions in blood pressure, whereas evidence for reflexology remains limited. The synergy between these modalities reflects convergent anti-inflammatory, vasodilatory, autonomic, and metabolic mechanisms, with additional benefits in adherence and patient well-being. Safety considerations highlight the need for vigilance regarding herb–drug interactions, product variability, and structured monitoring. Ongoing challenges include heterogeneous trial quality, inconsistent supplement formulations, and cautious guideline endorsement. Future directions emphasize precision pharmacotherapy, culturally sensitive integration, and AI-enabled digital health to personalize care. Collectively, a multimodal and evidence-informed approach offers synergistic potential to achieve blood pressure targets, mitigate cardiovascular risk, and improve holistic outcomes.